| Dataset | DGIdb Drug Targets 2026 |
| Category | physical interactions |
| Type | drug |
| Description | A dicarboximide that is pyrrolidine-2,5-dione in which the hydrogens at position 3 are substituted by one methyl and one ethyl group. An antiepileptic, it is used in the treatment of absence seizures and may be used for myoclonic seizures, but is ineffective against tonic-clonic seizures. (Chemical Entities of Biological Interest Ontology, CHEBI_4887) |
| External Link | https://dgidb.org/results?searchType=drug&searchTerms=ETHOSUXIMIDE |
| Similar Terms | |
| Downloads & Tools |
4 interacting proteins for the ETHOSUXIMIDE drug from theDGIdb Drug Targets 2026 dataset.
| Symbol | Name | Standardized Value |
|---|---|---|
| CACNA1G | calcium channel, voltage-dependent, T type, alpha 1G subunit | 1.65412 |
| CACNA1I | calcium channel, voltage-dependent, T type, alpha 1I subunit | 1.36893 |
| CACNA1H | calcium channel, voltage-dependent, T type, alpha 1H subunit | 0.863022 |
| SCN1A | sodium channel, voltage gated, type I alpha subunit | 0.848269 |
